These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 30634965)

  • 1. Sortilin levels are associated with peripheral arterial disease in type 2 diabetic subjects.
    Biscetti F; Bonadia N; Santini F; Angelini F; Nardella E; Pitocco D; Santoliquido A; Filipponi M; Landolfi R; Flex A
    Cardiovasc Diabetol; 2019 Jan; 18(1):5. PubMed ID: 30634965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sortilin/Omentin-1 ratio in peripheral artery disease: A cross-sectional study on 295 unselected elderly patients.
    Giovannini S; Biscetti F; Brau F; Biscotti L; Santoliquido A; Pitocco D; Bernabei R; Flex A
    Mech Ageing Dev; 2022 Jul; 205():111677. PubMed ID: 35500800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sortilin levels correlate with major cardiovascular events of diabetic patients with peripheral artery disease following revascularization: a prospective study.
    Biscetti F; Nardella E; Rando MM; Cecchini AL; Bonadia N; Bruno P; Angelini F; Di Stasi C; Contegiacomo A; Santoliquido A; Pitocco D; Landolfi R; Flex A
    Cardiovasc Diabetol; 2020 Sep; 19(1):147. PubMed ID: 32977814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating sortilin level as a potential biomarker for coronary atherosclerosis and diabetes mellitus.
    Oh TJ; Ahn CH; Kim BR; Kim KM; Moon JH; Lim S; Park KS; Lim C; Jang H; Choi SH
    Cardiovasc Diabetol; 2017 Jul; 16(1):92. PubMed ID: 28728579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of serum Cyr61 levels with peripheral arterial disease in subjects with type 2 diabetes.
    Feng B; Xu G; Sun K; Duan K; Shi B; Zhang N
    Cardiovasc Diabetol; 2020 Nov; 19(1):194. PubMed ID: 33222686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased sortilin and its independent effect on circulating proprotein convertase subtilisin/kexin type 9 (PCSK9) in statin-naive patients with coronary artery disease.
    Hu D; Yang Y; Peng DQ
    Int J Cardiol; 2017 Jan; 227():61-65. PubMed ID: 27846466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between plasma omentin-1 levels in type 2 diabetic patients and peripheral artery disease.
    Biscetti F; Nardella E; Bonadia N; Angelini F; Pitocco D; Santoliquido A; Filipponi M; Landolfi R; Flex A
    Cardiovasc Diabetol; 2019 Jun; 18(1):74. PubMed ID: 31167666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated serum fibroblast growth factor 23 levels as an indicator of lower extremity atherosclerotic disease in Chinese patients with type 2 diabetes mellitus.
    He X; Hu X; Ma X; Su H; Ying L; Peng J; Pan X; Bao Y; Zhou J; Jia W
    Cardiovasc Diabetol; 2017 Jun; 16(1):77. PubMed ID: 28619026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between omentin-1 and major cardiovascular events after lower extremity endovascular revascularization in diabetic patients: a prospective cohort study.
    Biscetti F; Nardella E; Rando MM; Cecchini AL; Angelini F; Cina A; Iezzi R; Filipponi M; Santoliquido A; Pitocco D; Landolfi R; Flex A
    Cardiovasc Diabetol; 2020 Oct; 19(1):170. PubMed ID: 33028322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of osteoprotegerin with peripheral artery disease in patients with type 2 diabetes.
    Esteghamati A; Aflatoonian M; Rad MV; Mazaheri T; Mousavizadeh M; Nakhjavani M; Noshad S
    Arch Cardiovasc Dis; 2015; 108(8-9):412-9. PubMed ID: 26184866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Markers of fibrinolysis may predict development of lower extremity arterial disease in patients with diabetes: A longitudinal prospective cohort study with 10 years of follow-up.
    Rautio A; Boman K; Eriksson JW; Svensson MK
    Diab Vasc Dis Res; 2016 May; 13(3):183-91. PubMed ID: 26818227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relation of Decreased Circulating Sortilin Levels With Unfavorable Metabolic Profiles in Subjects With Newly Diagnosed Type 2 Diabetes Mellitus.
    Demir İ; Yildirim Akan O; Guler A; Bozkaya G; Aslanipour B; Calan M
    Am J Med Sci; 2020 Jan; 359(1):8-16. PubMed ID: 31902442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osteoprotegerin concentration is associated with the presence and severity of peripheral arterial disease in type 2 diabetes mellitus.
    Demková K; Kozárová M; Malachovská Z; Javorský M; Tkáč I
    Vasa; 2018 Feb; 47(2):131-135. PubMed ID: 29313442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of plasma fetuin-a levels with peripheral arterial disease and lower extremity arterial calcification in subjects with type 2 diabetes mellitus.
    Eleftheriadou I; Grigoropoulou P; Kokkinos A; Mourouzis I; Perrea D; Katsilambros N; Sfikakis PP; Tentolouris N
    J Diabetes Complications; 2017 Mar; 31(3):599-604. PubMed ID: 27899247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma concentrations of lipoproteins and risk of lower-limb peripheral artery disease in people with type 2 diabetes: the SURDIAGENE study.
    Bertrand C; Saulnier PJ; Potier L; Croyal M; Blanchard V; Gand E; Ragot S; Schneider F; Bocock O; Baillet-Blanco L; Velho G; Marre M; Roussel R; Rigalleau V; Hadjadj S; Mohammedi K;
    Diabetologia; 2021 Mar; 64(3):668-680. PubMed ID: 33409569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of lower extremity peripheral artery disease among adult diabetes patients in southwestern Uganda.
    Okello S; Millard A; Owori R; Asiimwe SB; Siedner MJ; Rwebembera J; Wilson LA; Moore CC; Annex BH
    BMC Cardiovasc Disord; 2014 Jun; 14():75. PubMed ID: 24913468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of Statin Therapy on Plasma Proprotein Convertase Subtilisin/kexin Type 9 and Sortilin Levels in Statin-Naive Patients with Coronary Artery Disease.
    Nozue T; Hattori H; Ogawa K; Kujiraoka T; Iwasaki T; Michishita I
    J Atheroscler Thromb; 2016 Jul; 23(7):848-56. PubMed ID: 26797266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Presentations of major peripheral arterial disease and risk of major outcomes in patients with type 2 diabetes: results from the ADVANCE-ON study.
    Mohammedi K; Woodward M; Hirakawa Y; Zoungas S; Colagiuri S; Hamet P; Harrap S; Poulter N; Matthews DR; Marre M; Chalmers J;
    Cardiovasc Diabetol; 2016 Sep; 15(1):129. PubMed ID: 27590190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of micro- and macro-vascular disease and Tumor Necrosis Factor Receptor 1 on the level of lower-extremity amputation in patients with type 2 diabetes.
    Schneider F; Saulnier PJ; Gand E; Desvergnes M; Lefort N; Thorin E; Thorin-Trescases N; Mohammedi K; Ragot S; Ricco JB; Hadjadj S
    Cardiovasc Diabetol; 2018 Jun; 17(1):81. PubMed ID: 29879997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitamin D deficiency is associated with risk of developing peripheral arterial disease in type 2 diabetic patients.
    Yuan J; Jia P; Hua L; Xin Z; Yang JK
    BMC Cardiovasc Disord; 2019 Jun; 19(1):145. PubMed ID: 31208330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.